Aurobindo Pharma acquires Veritaz for Rs 171 crore in order to enter the domestic formulation business

Drug maker Aurobindo Pharma on Monday said it has acquired the domestic formulations business of Veritaz for Rs 171 crore on debt free and cash-free basis. This acquisition vehicle will greatly help Aurobindo as a launch pad for marketing biosimilar and other products in India, the company said in a statement. The transaction comes into effect from April 1, 2022 and is expected to by May 2022, the company said.

Read More
error

Enjoy this blog? Please spread the word :)

WhatsApp
LinkedIn
Share
Follow by Email
RSS
Testosteronas moterims : svarbus hormonas ir jo vaidmuo sveikatai. Farrest ship management (hong kong). Filing a dmca complaint is the start of a pre defined legal process.